Hyasynth Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10M

  • Investors
  • 24

Hyasynth General Information

Description

Producer of cannabinoid products intended to treat biosynthesis problems and contribute toward healthcare benefits. The company's products are made using technologies from traditional and modern biology combined with computational insights to develop organisms and treat multiple sclerosis, epilepsy and Alzheimer's diseases, enabling patients to get access to products that can help improve their health.

Contact Information

Website
www.hyasynthbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 141 avenue du Président-Kennedy
  • Local SB-5230, Casier 1
  • Montreal, Quebec H2X 1Y4
  • Canada
+1 (514)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Cannabis, FoodTech, Life Sciences
Corporate Office
  • 141 avenue du Président-Kennedy
  • Local SB-5230, Casier 1
  • Montreal, Quebec H2X 1Y4
  • Canada
+1 (514)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hyasynth Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A) 24-Dec-2021 $10M Completed Generating Revenue
8. Early Stage VC (Series B1) 23-Oct-2017 Completed Generating Revenue
7. Accelerator/Incubator 31-Jan-2017 Completed Generating Revenue
6. Accelerator/Incubator 13-Jul-2016 Completed Startup
5. Accelerator/Incubator 29-Jun-2015 Completed Startup
4. Accelerator/Incubator 13-Jan-2015 Completed Startup
3. Grant Completed Startup
2. Accelerator/Incubator $60K Completed Startup
1. Accelerator/Incubator 20-May-2014 $60K $60K Completed Startup
To view Hyasynth’s complete valuation and funding history, request access »

Hyasynth Patents

  • 38

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

Hyasynth Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220290194-A1 Cannabidiolic acid synthase variants with improved activity for use in production of phytocannabinoids Pending 20-Nov-2020
US-11427840-B2 Olivetolic acid cyclase variants with improved activity for use in production of phytocannabinoids Active 20-Nov-2020
CA-3195078-A1 Olivetolic acid cyclase variants with improved activity for use in production of phytocannabinoids Pending 20-Nov-2020
US-20220170055-A1 Olivetolic acid cyclase variants with improved activity for use in production of phytocannabinoids Active 20-Nov-2020
AU-2021381020-A1 Olivetolic acid cyclase variants with improved activity for use in production of phytocannabinoids Pending 20-Nov-2020 C12P7/42
To view Hyasynth’s complete patent history, request access »

Hyasynth Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hyasynth Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
OrganiGram Holdings Corporation
Anges Québec VC-Backed Company Minority
BoxOne Ventures Venture Capital Minority
Emmanuel Guyot Angel (individual) Minority
Groupe Roski Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

Ready to get started?

Request a free trial

Hyasynth FAQs

  • When was Hyasynth founded?

    Hyasynth was founded in 2014.

  • Where is Hyasynth headquartered?

    Hyasynth is headquartered in Montreal, Canada.

  • What is the size of Hyasynth?

    Hyasynth has 11 total employees.

  • What industry is Hyasynth in?

    Hyasynth’s primary industry is Biotechnology.

  • Is Hyasynth a private or public company?

    Hyasynth is a Private company.

  • What is Hyasynth’s current revenue?

    The current revenue for Hyasynth is .

  • How much funding has Hyasynth raised over time?

    Hyasynth has raised $11.6M.

  • Who are Hyasynth’s investors?

    OrganiGram Holdings, Anges Québec, BoxOne Ventures, Emmanuel Guyot, and Groupe Roski are 5 of 24 investors who have invested in Hyasynth.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »